117 related articles for article (PubMed ID: 3658567)
1. Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder.
Pelham WE; Sturges J; Hoza J; Schmidt C; Bijlsma JJ; Milich R; Moorer S
Pediatrics; 1987 Oct; 80(4):491-501. PubMed ID: 3658567
[TBL] [Abstract][Full Text] [Related]
2. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
[TBL] [Abstract][Full Text] [Related]
3. Comparison of sustained-release and standard methylphenidate in the treatment of minimal brain dysfunction.
Whitehouse D; Shah U; Palmer FB
J Clin Psychiatry; 1980 Aug; 41(8):282-5. PubMed ID: 7400107
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children.
Prescrire Int; 2004 Dec; 13(74):203-6. PubMed ID: 15612099
[TBL] [Abstract][Full Text] [Related]
5. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder.
Fitzpatrick PA; Klorman R; Brumaghim JT; Borgstedt AD
J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):226-34. PubMed ID: 1564023
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate dosing: twice daily versus three times daily.
Stein MA; Blondis TA; Schnitzler ER; O'Brien T; Fishkin J; Blackwell B; Szumowski E; Roizen NJ
Pediatrics; 1996 Oct; 98(4 Pt 1):748-56. PubMed ID: 8885956
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.
Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H
Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682
[TBL] [Abstract][Full Text] [Related]
8. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment.
Gadow KD; Nolan E; Sprafkin J; Sverd J
J Dev Behav Pediatr; 1995 Jun; 16(3):167-76. PubMed ID: 7560119
[TBL] [Abstract][Full Text] [Related]
9. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
10. Effects of methylphenidate and expectancy on children with ADHD: behavior, academic performance, and attributions in a summer treatment program and regular classroom settings.
Pelham WE; Hoza B; Pillow DR; Gnagy EM; Kipp HL; Greiner AR; Waschbusch DA; Trane ST; Greenhouse J; Wolfson L; Fitzpatrick E
J Consult Clin Psychol; 2002 Apr; 70(2):320-35. PubMed ID: 11952190
[TBL] [Abstract][Full Text] [Related]
11. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder.
Steele M; Weiss M; Swanson J; Wang J; Prinzo RS; Binder CE
Can J Clin Pharmacol; 2006; 13(1):e50-62. PubMed ID: 16456216
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate hydrochloride given with or before breakfast: I. Behavioral, cognitive, and electrophysiologic effects.
Swanson JM; Sandman CA; Deutsch C; Baren M
Pediatrics; 1983 Jul; 72(1):49-55. PubMed ID: 6866591
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
[TBL] [Abstract][Full Text] [Related]
15. Components of attention, methylphenidate dosage, and blood levels in children with attention deficit disorder.
Sebrechts MM; Shaywitz SE; Shaywitz BA; Jatlow P; Anderson GM; Cohen DJ
Pediatrics; 1986 Feb; 77(2):222-8. PubMed ID: 3945535
[TBL] [Abstract][Full Text] [Related]
16. Sustained release methylphenidate: pharmacokinetic studies in ADDH males.
Birmaher B; Greenhill LL; Cooper TB; Fried J; Maminski B
J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):768-72. PubMed ID: 2793805
[TBL] [Abstract][Full Text] [Related]
17. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
Levin FR; Evans SM; Brooks DJ; Kalbag AS; Garawi F; Nunes EV
Drug Alcohol Depend; 2006 Feb; 81(2):137-48. PubMed ID: 16102908
[TBL] [Abstract][Full Text] [Related]
18. The effect of methylphenidate on the cognitive and personality functioning of ADHD children.
Lufi D; Parish-Plass J; Gai E
Isr J Psychiatry Relat Sci; 1997; 34(3):200-9. PubMed ID: 9334525
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
